Malignant hypertension overview: Difference between revisions

Jump to navigation Jump to search
(Created page with "__NOTOC__ {{Malignant hypertension}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==References==...")
 
No edit summary
 
(3 intermediate revisions by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Malignant hypertension}}
{{Malignant hypertension}}
{{CMG}}
== Overview ==


Please help WikiDoc by adding content here. It's easy!  Click  [[Help:How_to_Edit_a_Page|here]] to learn about editing.
Malignant hypertension is a complication of [[hypertension]] characterized by very elevated [[blood pressure]], and organ damage in the [[eye]]s, [[brain]], [[lung]] and/or [[kidney]]s. It differs from other complications of hypertension in that it is accompanied by [[papilledema]]. [[Systolic]] and [[diastolic]] [[blood pressure]]s are usually greater than 200 and 140, respectively.
==Diagnosis==
===Electrocardiogram===
The ECG is necessary to screen for ischemia, infarct, or evidence of electrolyte abnormalities or drug overdose.
===X Ray===
The chest radiograph is useful for assessment of cardiac enlargement, [[pulmonary edema]], or involvement of other thoracic structures, such as rib notching with aortic coarctation or a widened [[mediastinum]] with [[aortic dissection]]. Other tests, such as head CT scan, transesophageal echocardiogram, and renal angiography, are indicated only as directed by the initial workup.
==Treatment==
===Medical Therapy===
The most commonly used intravenous drug is [[nitroprusside]]. An alternative for patients with renal insufficiency is intravenous [[fenoldopam]]. [[Labetalol]] is another common alternative, providing easy transition from IV to oral (PO) dosing. Beta-blockade can be accomplished intravenously with [[esmolol]] or [[metoprolol]]. [[Hydralazine]] is reserved for use in pregnant patients, while [[phentolamine]] is the drug of choice for a [[pheochromocytoma]] crisis. iv sodium nitroprusside should be used with caution as it can cause a rapid uncontrollable drop in blood pressure.


==References==
==References==
{{Reflist|2}}
{{Reflist|2}}


[[Category:Needs content]]
[[Category:Medical emergencies]]
[[Category:Medical emergencies]]
[[Category:Intensive care medicine]]
[[Category:Intensive care medicine]]

Latest revision as of 20:19, 22 February 2013

Malignant hypertension Microchapters

Home

Patient Information

Overview

Historical Perspective

Pathophysiology

Causes

Differentiating Malignant hypertension from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Malignant hypertension overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Malignant hypertension overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Malignant hypertension overview

CDC on Malignant hypertension overview

Malignant hypertension overview in the news

Blogs on Malignant hypertension overview

Directions to Hospitals Treating Malignant hypertension

Risk calculators and risk factors for Malignant hypertension overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Malignant hypertension is a complication of hypertension characterized by very elevated blood pressure, and organ damage in the eyes, brain, lung and/or kidneys. It differs from other complications of hypertension in that it is accompanied by papilledema. Systolic and diastolic blood pressures are usually greater than 200 and 140, respectively.

Diagnosis

Electrocardiogram

The ECG is necessary to screen for ischemia, infarct, or evidence of electrolyte abnormalities or drug overdose.

X Ray

The chest radiograph is useful for assessment of cardiac enlargement, pulmonary edema, or involvement of other thoracic structures, such as rib notching with aortic coarctation or a widened mediastinum with aortic dissection. Other tests, such as head CT scan, transesophageal echocardiogram, and renal angiography, are indicated only as directed by the initial workup.

Treatment

Medical Therapy

The most commonly used intravenous drug is nitroprusside. An alternative for patients with renal insufficiency is intravenous fenoldopam. Labetalol is another common alternative, providing easy transition from IV to oral (PO) dosing. Beta-blockade can be accomplished intravenously with esmolol or metoprolol. Hydralazine is reserved for use in pregnant patients, while phentolamine is the drug of choice for a pheochromocytoma crisis. iv sodium nitroprusside should be used with caution as it can cause a rapid uncontrollable drop in blood pressure.

References


Template:WikiDoc Sources